not tagged
bms
with bcma targeted car-t therapy we may miss these patients that relapse with bcma low. car-t co-transduction and dual targeting engineering approaches are the key to overcome resistance. extraordinary presentation by dr. eric smith #ims2022 
Pharmaceutical Chemistry PhD, working at the interface between Drug Discovery and Cancer Biology, made in Italy, living in US. Italian Consular Correspondent.